search
Back to results

Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants

Primary Purpose

Complication of Prematurity

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Powder HMF
Liquid HMF
Sponsored by
University of Kansas Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Complication of Prematurity focused on measuring prematurity, growth, nutrition, human milk fortifier

Eligibility Criteria

28 Weeks - 34 Weeks (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Inborn preterm infants born between 28 0/7 and 34 0/7 weeks gestation and fed either mother's own milk or donor human milk

Exclusion Criteria:

  • Newborn infants <28 weeks and >34 weeks gestation, those with life threatening illness, congenital and chromosomal anomalies, gastrointestinal anomalies or necrotizing enterocolitis and fed premature formula

Sites / Locations

  • University of Kansas Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Powder HMF

Liquid HMF

Arm Description

Once patient has reached 80ml/kg/day of enteral feedings, 1 pack of powder HMF will be added to 50 ml of human or donor breast milk, then increased to a maximum of 2 packs for 50 ml following the unit feeding advancement protocol and this will be continued up until 48 hours prior to discharge.

Once patient has reached 80ml/kg/day of enteral feedings, researchers will add 1 packet (5 ml) of liquid HMF to 50 ml of human or donor breast milk, then increase to 2 packs to 50 ml following the unit feeding protocol and this will be continued up until 48 hours prior to discharge.

Outcomes

Primary Outcome Measures

Cumulative weight gain
Weight gain of baby during the course of the study
Change in weight
Weight gain of baby week-to-week, during the course of the study
Linear length
change in length week-to-week during the course of the study
Head growth
Change in head measurements week-to-week during the course of the study

Secondary Outcome Measures

Nutrition biomarkers
Measurements of a baby's Ca, P, Mg, Alkaline Phosphatase and Prealbumin will be taken
Tolerance to enteral feeds
number of significant residuals, number of times feeds were held, NEC

Full Information

First Posted
December 10, 2015
Last Updated
September 1, 2020
Sponsor
University of Kansas Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02632266
Brief Title
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
Official Title
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
July 2015 (undefined)
Primary Completion Date
May 2019 (Actual)
Study Completion Date
May 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Kansas Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is for the researchers to examine the safety and efficacy of liquid human milk fortifier (HMF) in moderately preterm infants compared to powdered human milk fortifier.
Detailed Description
This is a prospective, randomize, double-blinded study in preterm infants born between 28-34 weeks gestation admitted to the NICU at the University of Kansas Hospital. After obtaining informed consent, babies will be randomized to either liquid or powdered HMF using opaque, sealed envelopes with preassigned randomization. The feeding protocol as established in the KU NICU will be followed, beginning with initiation of trophic feeds, and advancement of enteral feeds depending on the gestational age and preceding illnesses. Once infants reach 80ml/kg/day of enteral feeds, human milk will be fortified to 22 kilocalories by adding either liquid or powdered fortifier. The beginning of the study(Study day 1) will be defined as reaching and tolerating 100ml/kg/day of 24 kilocalorie human milk fortified with either liquid or powdered fortifier. Enteral feeds will be advanced per unit protocol until they reach 150-160ml/kg/day and 110-120 kcal/kg/day. the volume of feeds will be adjusted based on the documented weight to provide energy and protein requirements as recommended by the ESPGHAN guidelines. Babies will be followed up until the time of NICU discharge.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complication of Prematurity
Keywords
prematurity, growth, nutrition, human milk fortifier

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Powder HMF
Arm Type
Active Comparator
Arm Description
Once patient has reached 80ml/kg/day of enteral feedings, 1 pack of powder HMF will be added to 50 ml of human or donor breast milk, then increased to a maximum of 2 packs for 50 ml following the unit feeding advancement protocol and this will be continued up until 48 hours prior to discharge.
Arm Title
Liquid HMF
Arm Type
Active Comparator
Arm Description
Once patient has reached 80ml/kg/day of enteral feedings, researchers will add 1 packet (5 ml) of liquid HMF to 50 ml of human or donor breast milk, then increase to 2 packs to 50 ml following the unit feeding protocol and this will be continued up until 48 hours prior to discharge.
Intervention Type
Dietary Supplement
Intervention Name(s)
Powder HMF
Intervention Description
powder human milk fortifier
Intervention Type
Dietary Supplement
Intervention Name(s)
Liquid HMF
Intervention Description
Liquid human milk fortifier
Primary Outcome Measure Information:
Title
Cumulative weight gain
Description
Weight gain of baby during the course of the study
Time Frame
Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier
Title
Change in weight
Description
Weight gain of baby week-to-week, during the course of the study
Time Frame
Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier
Title
Linear length
Description
change in length week-to-week during the course of the study
Time Frame
Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier
Title
Head growth
Description
Change in head measurements week-to-week during the course of the study
Time Frame
Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier
Secondary Outcome Measure Information:
Title
Nutrition biomarkers
Description
Measurements of a baby's Ca, P, Mg, Alkaline Phosphatase and Prealbumin will be taken
Time Frame
Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier
Title
Tolerance to enteral feeds
Description
number of significant residuals, number of times feeds were held, NEC
Time Frame
Baseline to 36 Weeks post-conceptional age or Study Day 28, whichever is earlier

10. Eligibility

Sex
All
Minimum Age & Unit of Time
28 Weeks
Maximum Age & Unit of Time
34 Weeks
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Inborn preterm infants born between 28 0/7 and 34 0/7 weeks gestation and fed either mother's own milk or donor human milk Exclusion Criteria: Newborn infants <28 weeks and >34 weeks gestation, those with life threatening illness, congenital and chromosomal anomalies, gastrointestinal anomalies or necrotizing enterocolitis and fed premature formula
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vishal Pandey, MD
Organizational Affiliation
University of Kansas Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
9724686
Citation
Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics. 1998 Sep;102(3):E38. doi: 10.1542/peds.102.3.e38.
Results Reference
result
PubMed Identifier
1979363
Citation
Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990 Dec 22-29;336(8730):1519-23. doi: 10.1016/0140-6736(90)93304-8.
Results Reference
result
PubMed Identifier
3373407
Citation
Greer FR, McCormick A. Improved bone mineralization and growth in premature infants fed fortified own mother's milk. J Pediatr. 1988 Jun;112(6):961-9. doi: 10.1016/s0022-3476(88)80227-0. Erratum In: J Pediatr 1988 Dec;113(6):1118.
Results Reference
result
PubMed Identifier
25102321
Citation
Cibulskis CC, Armbrecht ES. Association of metabolic acidosis with bovine milk-based human milk fortifiers. J Perinatol. 2015 Feb;35(2):115-9. doi: 10.1038/jp.2014.143. Epub 2014 Aug 7.
Results Reference
result
PubMed Identifier
24394538
Citation
Thoene M, Hanson C, Lyden E, Dugick L, Ruybal L, Anderson-Berry A. Comparison of the effect of two human milk fortifiers on clinical outcomes in premature infants. Nutrients. 2014 Jan 3;6(1):261-75. doi: 10.3390/nu6010261.
Results Reference
result
PubMed Identifier
19881390
Citation
Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, Domellof M, Embleton ND, Fusch C, Genzel-Boroviczeny O, Goulet O, Kalhan SC, Kolacek S, Koletzko B, Lapillonne A, Mihatsch W, Moreno L, Neu J, Poindexter B, Puntis J, Putet G, Rigo J, Riskin A, Salle B, Sauer P, Shamir R, Szajewska H, Thureen P, Turck D, van Goudoever JB, Ziegler EE; ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):85-91. doi: 10.1097/MPG.0b013e3181adaee0.
Results Reference
result

Learn more about this trial

Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants

We'll reach out to this number within 24 hrs